FIELD: medicine.
SUBSTANCE: in the patient's blood serum the concentration of matrix metalloproteinase - 9 (MMP-9) and/or procollagen 1 C-terminal propeptide (PICP) is determined. If the value MMP-9 is larger than 101.8 ng/ml and/or PICP 195.6 ng/ml the unfavourable course of IHD is predicted, if lower than these values - the favourable course without the formation of critical stenoses in the coronary arteries.
EFFECT: increased accuracy and specificity of the method.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING THE RISK OF DEVELOPING ADVERSE OUTCOMES WITHIN THE FIRST YEAR FOLLOWING THE PERCUTANEOUS CORONARY INTERVENTION WITH STENTING IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE | 2018 |
|
RU2692257C1 |
| METHOD OF DIAGNOSTICS OF INTRATHORACIC ARTERY ENDOTHELIAL DYSFUNCTION | 2007 |
|
RU2345712C2 |
| METHOD FOR DETERMINING INDICATIONS TO SURGICAL TREATMENT OF CARDIAC ISCHEMIA PATIENTS SURVIVED AFTER MYOCARDIAL INFARCTION | 2004 |
|
RU2269934C1 |
| METHOD FOR INDUCTION OF EXTRACARDIAL MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH CORONARY HEART DISEASE | 2021 |
|
RU2758024C1 |
| METHOD FOR DIAGNOSIS OF CORONARY ARTERY STENOSIS RESTENOSIS IN PATIENTS WITH CORONARY HEART DISEASE WITH CHRONIC HEART FAILURE | 2017 |
|
RU2649131C1 |
| METHOD OF PREDICTING ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ETIOLOGY WITHIN A YEAR AFTER CORONARY ARTERY BYPASS GRAFTING | 2022 |
|
RU2801160C1 |
| METHODS FOR DETERMINATION OF INDICATIONS FOR SINGLE-DAY HOSPITALIZATION FOR X-RAY ENDOVASCULAR TREATMENT OF CORONARY ARTERIES AND TO PATIENT DISCHARGE NEXT DAY AFTER OPERATION | 2017 |
|
RU2644930C1 |
| DIAGNOSTIC TECHNIQUE FOR DISPOSITION TO ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASES BY PERIPHERAL BLOOD INTERLEUKIN-10-PRODUCING LYMPHOCYTE COUNT | 2014 |
|
RU2575791C1 |
| METHOD OF DETERMINING VASODILATING REACTION OF NITROGLYCERIN IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2010 |
|
RU2444278C2 |
| METHOD FOR PREDICTION OF RISK OF UNFAVOURABLE CARDIOVASCULAR EVENTS IN PATIENTS SUFFERING ISCHEMIC HEART DISEASE WITH ISCHEMIC AND/OR POSTINFARCTION MYOCARDIAL DYSFUNCTION ACCOMPANYING CHRONIC CARDIAL INSUFFICIENCY | 2014 |
|
RU2568577C1 |
